A023910 Stock Overview
Daihan Pharmaceutical Co.,Ltd. se dedica a la fabricación y venta de medicamentos terapéuticos en Corea del Sur.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Daihan Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩28,150.00 |
| 52 Week High | ₩30,300.00 |
| 52 Week Low | ₩25,500.00 |
| Beta | 0.32 |
| 1 Month Change | -1.75% |
| 3 Month Change | 0.72% |
| 1 Year Change | -2.09% |
| 3 Year Change | -27.45% |
| 5 Year Change | -28.73% |
| Change since IPO | 650.67% |
Recent News & Updates
Recent updates
Here's Why Daihan PharmaceuticalLtd (KOSDAQ:023910) Can Manage Its Debt Responsibly
Mar 02
Daihan Pharmaceutical Co.,Ltd.'s (KOSDAQ:023910) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
Feb 09
Can You Imagine How Daihan PharmaceuticalLtd's (KOSDAQ:023910) Shareholders Feel About The 34% Share Price Increase?
Jan 19What Kind Of Shareholders Hold The Majority In Daihan Pharmaceutical Co.,Ltd.'s (KOSDAQ:023910) Shares?
Dec 18Does Daihan PharmaceuticalLtd (KOSDAQ:023910) Have A Healthy Balance Sheet?
Nov 27Shareholder Returns
| A023910 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -0.9% | -6.6% | -1.9% |
| 1Y | -2.1% | 11.6% | 7.4% |
Rentabilidad frente al sector: A023910 obtuvo unos resultados inferiores a los del sector KR Pharmaceuticals , que el año pasado arrojó un rendimiento del 15.6%.
Rentabilidad vs. Mercado: A023910 obtuvo unos resultados inferiores a los del mercado KR, que fue del 8.1% el año pasado.
Price Volatility
| A023910 volatility | |
|---|---|
| A023910 Average Weekly Movement | 2.1% |
| Pharmaceuticals Industry Average Movement | 4.9% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Precio estable de las acciones: A023910 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de A023910 (2%) se ha mantenido estable durante el año pasado.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1945 | n/a | Sungyoung Lee | https://www.daihan.com |
Daihan Pharmaceutical Co.,Ltd. se dedica a la fabricación y venta de medicamentos terapéuticos en Corea del Sur. La empresa ofrece diversos fármacos, como medicamentos con receta, de venta libre y cuasifármacos, así como diversas soluciones relacionadas con la infusión.
Daihan Pharmaceutical Co.,Ltd. Fundamentals Summary
| A023910 fundamental statistics | |
|---|---|
| Market cap | ₩165.52b |
| Earnings (TTM) | ₩28.43b |
| Revenue (TTM) | ₩195.91b |
5.8x
P/E Ratio0.8x
P/S RatioIs A023910 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A023910 income statement (TTM) | |
|---|---|
| Revenue | ₩195.91b |
| Cost of Revenue | ₩130.60b |
| Gross Profit | ₩65.31b |
| Other Expenses | ₩36.89b |
| Earnings | ₩28.43b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.83k |
| Gross Margin | 33.34% |
| Net Profit Margin | 14.51% |
| Debt/Equity Ratio | 0% |
How did A023910 perform over the long term?
See historical performance and comparison